Twin Peaks Wealth Advisors, LLC Jazz Pharmaceuticals PLC Transaction History
Twin Peaks Wealth Advisors, LLC
- $309 Billion
- Q2 2025
A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 18 shares of JAZZ stock, worth $2,471. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$2,471% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
562Shares Held
62.7MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$844 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$836 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$351 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$349 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$348 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.61B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...